Tenofovir-induced severe hepatitis in occult hepatitis B reactivation

Dig Liver Dis. 2015 Oct;47(10):898-9. doi: 10.1016/j.dld.2015.06.013. Epub 2015 Jul 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Hepatitis B / drug therapy*
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Humans
  • Immunocompromised Host / drug effects
  • Liver Function Tests
  • Lymphoma, Large B-Cell, Diffuse / diagnosis
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Rituximab
  • Tenofovir / adverse effects*
  • Tenofovir / therapeutic use
  • Vincristine / therapeutic use
  • Virus Activation*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antiviral Agents
  • R-CHOP protocol
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Tenofovir
  • Prednisone